Process evaluation showing the importance of co-located, high-intensity and person-centred smoking cessation support in a lung cancer screening setting
Year: 2026
Type: article
Abstract: Evidence regarding optimal integration of smoking cessation is needed to inform implementation of lung cancer screening (LCS) and reduce smoking-related inequalities. The Yorkshire Enhanced Stop Smoking Randomised Controlled Trial tested opt-out, co-located standard best practice (SBP) smoking cessation support (control) versus SBP enhanced with theory-informed, personalised risk information derived from participants’ lung scan results to boost quit motivation (intervention). The intervention was tailored to degree of lung/heart damage, and designed to optimise self-efficacy and response-efficacy for quitting smoking 1 . Smoking cessation practitioners (SCPs) received bespoke intervention training in delivering theory-informed behaviour change techniques (BCTs). We conducted a nested process evaluation to evaluate the implementation of optimised smoking cessation support compared to SBP. Semi-structured interviews were carried out with 45 trial participants and eight SCPs at 4-, 12- and 52-weeks after screening (participants) or training (SCPs). Interviews were analysed thematically to assess intervention fidelity, exposure, context, contamination and theory. Observations of SCP consultations on the mobile screening unit (n = 84; 4%) and 4-weeks after screening (n = 132; 13%) were analysed to test fidelity, context and contamination. Intervention context was paramount: participants in both trial arms described benefits of co-located and ongoing high-intensity smoking cessation support, with immediate provision of pharmacotherapy. Tailored, non-judgemental care was considered key to initiating and sustaining quitting, particularly for participants at various points along their quit pathway and awaiting a possible lung cancer diagnosis. Fidelity was high (97%) on the screening unit and moderate (75%) 4-weeks after screening, and moderate for the enhanced intervention (77%) 4-weeks after screening. SBP and the intervention was flexibly delivered according to time constraints, participant motivation to quit, anxiety about screening and screening and/or booklet results. There was variation in how participants used and shared their booklets (exposure). Contamination of SCP intervention training was observed, with SCPs delivering theory-informed BCTs across both trial arms e.g. using the LCS context to boost response-efficacy beliefs. Provision of co-located, high intensity and person-centred smoking cessation support was vital, irrespective of trial arm. Investment in specialist LCS smoking cessation practitioners may harness the benefits of LCS as a teachable moment for cessation. Trial registration : www.clinicaltrials.gov/study/NCT03750110 (registered 21/11/2018).
Source: Scientific Reports
Institutions: Wales Cancer Research Centre, Cardiff University, Johns Hopkins University, Queen Mary University of London, University of Leeds, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, University of Nottingham, Nottingham City Hospital, Nottingham University Hospitals NHS Trust, University of Manchester, Wythenshawe Hospital, University of York
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W4400775229
